The article will also look at the side effects of semaglutide and what current research says about its potential role in pain management
these mediate a slowdown in gastric emptying, with an increase in the sense of satiety reduced hunger and lower energy intake [4, 5]
What they're saying: According to the lawsuit, one of the plaintiffs switched from Zepbound to Wegovy in August after exhausting all appeals to Caremark, then "experienced a number of side effects, including the return of his Gastroesophageal Reflux Disease, stomach pain, hunger, and, most notably, weight gain." "Because of their different methods of action, different clinical outcomes, and different side effects for individual patients, Zepbound and Wegovy are not clinically interchangeable," the lawsuit states
Appetite Suppression: Reduces hunger by acting on brain receptors